ArticleMedical oncology (Northwood, London, England)2019

Correlation between the magnitude of best tumor response and patient survival in nivolumab therapy for metastatic renal cell carcinoma.

Hiroki Ishihara et al.PubMed ↗Publisher ↗

No numbers read from the abstract.